case report | Q2782326 |
scholarly article | Q13442814 |
P50 | author | Massimo Zeviani | Q28321912 |
Costanza Lamperti | Q28321919 | ||
Daniele Ghezzi | Q30093362 | ||
Leslie G Biesecker | Q65054829 | ||
P2093 | author name string | Kenneth H Fischbeck | |
Barrington G Burnett | |||
Christopher Grunseich | |||
Guida Landouré | |||
Carlo Rinaldi | |||
Irina F Sevrioukova | |||
Iren Horkayne-Szakaly | |||
Carsten Bönnemann | |||
Marina L Kennerson | |||
Alice Schindler | |||
P2860 | cites work | Molecular characterization of mitochondrial apoptosis-inducing factor | Q22001452 |
Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space | Q24298363 | ||
Connexin mutations in X-linked Charcot-Marie-Tooth disease | Q24323296 | ||
Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5) | Q24337506 | ||
The crystal structure of the mouse apoptosis-inducing factor AIF | Q27638885 | ||
Redox-Linked Conformational Dynamics in Apoptosis-Inducing Factor | Q27655498 | ||
Diagnosis, natural history, and management of Charcot–Marie–Tooth disease | Q28111977 | ||
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death | Q28209183 | ||
Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death | Q33669499 | ||
Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor | Q33772997 | ||
The harlequin mouse mutation downregulates apoptosis-inducing factor | Q34152182 | ||
Apoptosis-inducing factor: structure, function, and redox regulation | Q34987223 | ||
The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine | Q37363150 | ||
AIF deficiency compromises oxidative phosphorylation | Q37671807 | ||
Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation | Q38292207 | ||
NADH oxidase activity of mitochondrial apoptosis-inducing factor | Q43559779 | ||
Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor | Q46155629 | ||
Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing | Q46832645 | ||
Loss of apoptosis-inducing factor leads to an increase in reactive oxygen species, and an impairment of respiration that can be reversed by antioxidants. | Q47718701 | ||
X-linked motor-sensory neuropathy type-II with deafness and mental retardation: a new disorder. | Q50584676 | ||
A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26. | Q52013511 | ||
Genetic and clinical aspects of Charcot-Marie-Tooth's disease | Q68829086 | ||
X-linked neuropathy: gene localization with DNA probes | Q70156209 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | apoptotic process | Q14599311 |
Apoptosis inducing factor mitochondria associated 1 | Q21116445 | ||
oxidoreductase activity, acting on NAD(P)H | Q21763012 | ||
P304 | page(s) | 1095-102 | |
P577 | publication date | 2012-12-07 | |
P1433 | published in | American Journal of Human Genetics | Q4744249 |
P1476 | title | Cowchock syndrome is associated with a mutation in apoptosis-inducing factor | |
P478 | volume | 91 |
Q38589445 | A Review of X-linked Charcot-Marie-Tooth Disease |
Q55435412 | A disease-associated Aifm1 variant induces severe myopathy in knockin mice. |
Q28246639 | A mutation of COX6A1 causes a recessive axonal or mixed form of Charcot-Marie-Tooth disease |
Q47702623 | A newly distal hereditary motor neuropathy caused by a rare AIFM1 mutation. |
Q38502090 | A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease |
Q55286697 | A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS. |
Q47829716 | A novel missense mutation in AIFM1 results in axonal polyneuropathy and misassembly of OXPHOS complexes. |
Q30397903 | A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disorders |
Q36270879 | AIF inhibits tumor metastasis by protecting PTEN from oxidation |
Q62016936 | AIF promotes a JNK1-mediated cadherin switch independently of respiratory chain stabilization |
Q37678110 | AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant |
Q57299773 | Apoptosis inducing factor deficiency causes retinal photoreceptor degeneration. The protective role of the redox compound methylene blue |
Q55265243 | Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer. |
Q35997632 | Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells. |
Q36998017 | CHCHD4 links AIF to the biogenesis of respiratory chain complex I. |
Q38201741 | Charcot-Marie-Tooth disease and pathways to molecular based therapies |
Q46150120 | Defining NADH-Driven Allostery Regulating Apoptosis-Inducing Factor |
Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
Q64898477 | Diagnostic Yields of Trio-WES Accompanied by CNVseq for Rare Neurodevelopmental Disorders. |
Q35984327 | Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy |
Q33620795 | Exome sequencing reveals HINT1 mutations as a cause of distal hereditary motor neuropathy |
Q92180784 | Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series |
Q28077589 | Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration |
Q36293830 | Loss of apoptosis-inducing factor critically affects MIA40 function. |
Q36187248 | Metabolic epistasis among apoptosis-inducing factor and the mitochondrial import factor CHCHD4. |
Q52807500 | Microscale 3D Liver Bioreactor for In Vitro Hepatotoxicity Testing under Perfusion Conditions. |
Q38932389 | Mitochondrial disulfide relay and its substrates: mechanisms in health and disease. |
Q38736014 | Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis. |
Q30405518 | Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder |
Q33724242 | Neuroglobin gene therapy prevents optic atrophy and preserves durably visual function in Harlequin mice |
Q37686243 | Next-generation sequencing for mitochondrial disorders |
Q36184604 | Next-generation sequencing in X-linked intellectual disability |
Q38139602 | Peripheral neuropathy in mitochondrial disorders |
Q28118095 | SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease |
Q50316569 | Spondyloepimetaphyseal dysplasia with neurodegeneration associated with AIFM1 mutation - a novel phenotype of the mitochondrial disease. |
Q36246291 | The Effect of a Novel c.820C>T (Arg274Trp) Mutation in the Mitofusin 2 Gene on Fibroblast Metabolism and Clinical Manifestation in a Patient. |
Q98733497 | The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation |
Q55027001 | WAH-1/AIF regulates mitochondrial oxidative phosphorylation in the nematode Caenorhabditis elegans. |
Q92684439 | Whole exome sequencing identifies a novel variant in an apoptosis-inducing factor gene associated with X-linked recessive hearing loss in a Chinese family |
Q57171854 | X-Linked Sensorineural Hearing Loss: A Literature Review |
Q54220036 | X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene. |
Q40156896 | X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome. |
Q47124322 | X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1. |